SGO 2019: In Recurrent Ovarian Cancer, Niraparib Tolerability Improves by Starting With 200 and 300 mg Based on Body Weight and Platelet Count
Baseline platelet count and body weight can be used to determine optimal niraparib dosing.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.